Skip to main content
Liezl Gamble Photo
Liezl Gambe

Liezl Gambe

GrafaFinance Journalist

Finance journalist at Grafa with years of experience covering Asia-Pacific financial markets at S&P Global, Mortgage Ezy, and GMA Network.

Articles by Liezl Gambe

Grafa
Health

Aldeyra plans FDA appeal for reproxalap dry eye treatment application

Aldeyra Therapeutics (NASDAQ:ALDX) announced plans to submit a Formal Dispute Resolution Request (FDRR) to the U.S. Food and Drug Administration (FDA) seeking review of the agency’s decision not to approve reproxalap, its investigational therapy for dry eye disease.

Read more: Aldeyra plans FDA appeal for reproxalap dry eye treatment application